A non-HIV player can't really use us to launch a p
Post# of 148168
(Total Views: 450)
Posted On: 08/30/2019 2:28:29 PM
A non-HIV player can't really use us to launch a product line with only combo approval, right? They need the mono to go forward or they are just pushing their Leronlimab as a supplement to a competitor's product. Tough sell. Obviously need this BLA to get done, but there are limited buyers without mono.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼